Fc-Free Single Chain Antibody mRNA Therapy for Airway Infection of Multidrug-Resistant Pseudomonas Aeruginosa
Kinoshita, M.; Kawaguchi, K.; Le, N. B.; Kainuma, A.; Sawa, T.; Uchida, S.
Show abstract
With the growing threat of antimicrobial resistance (AMR), alternatives to antibiotics are urgently needed. In this study, we developed mRNA-based therapeutics encoding single-chain variable fragment (scFv) antibodies that target the type III secretion system of Pseudomonas aeruginosa, a key AMR pathogen. Delivered intravenously via lipid nanoparticles, the scFv mRNA effectively protected mice from airway infections by mitigating lung inflammation, reducing bacterial load, and improving survival. Notably, this approach proved effective in clinically relevant models involving immunocompromised mice infected with multidrug-resistant, exoU-positive (highly cytotoxic) clinical isolates. The study also explores the potential of Fc-free scFv formulations, leveraging mRNA technology to overcome their short half-life through sustained protein production. Importantly, Fc-free scFv antibodies migrated more efficiently from the bloodstream to the airway epithelium--the primary site of infection--than their Fc-conjugated counterparts, resulting in efficient therapeutic outcomes. Overall, mRNA-encoded Fc-free scFv antibodies represent a promising strategy for combating AMR infections.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tuberculosis biomarkers discovered using Diversity Outbred mice 94%
- Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters 93%
- Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model 93%
Similar papers in this journal
- Monoclonal IgM antibodies raised against Candida albicans Hyr1 provide cross-kingdom protection against Gram negative bacteria 96%
- A Novel Humanized Mouse Model for HIV and Tuberculosis Co-infection Studies 94%
- A Murine Model of Post-acute Neurological Sequelae Following SARS-CoV-2 Variant Infection 94%
Similar papers in this journal
- Murine Alveolar Macrophages Rapidly Accumulate Intranasally Administered SARS-CoV-2 Spike Protein leading to Neutrophil Recruitment and Damage 94%
- A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus 93%
- Ym1 protein crystals promote type 2 immunity 93%
Similar papers in this journal
- Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M nanoparticle vaccine induces neutralizing responses in nonhuman primates 94%
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice 94%
- Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.